Keyphrases
Age of Onset
10%
Anti-centromere Antibody
10%
Anti-topoisomerase I Antibodies
10%
Autoantibody Profile
10%
CD247
10%
Complex Susceptibility
10%
Disease Pattern
10%
Disease Severity
10%
Family Registry
10%
Forced Vital Capacity
20%
Gene Variants
10%
Genome-wide Association Study
20%
Genome-wide Significance
10%
Independent Replication
10%
Interferon Regulatory Factor 5 (IRF5)
100%
Interstitial Lung Disease
30%
Johns Hopkins
10%
Long-term Survival
20%
Major Histocompatibility Complex
10%
Minor Allele
30%
Minor Allele Frequency
10%
Non-majors
10%
Polymorphism
100%
Prognosis Prediction
100%
Promoter Region
10%
Scleroderma
30%
Single nucleotide Polymorphism
10%
SNP
30%
STAT4
10%
Susceptibility Loci
10%
Systemic Sclerosis
100%
Transcript Expression
10%
Transcript Level
10%
Immunology and Microbiology
Allele
30%
Autoantibodies
10%
CD247
10%
Forced Vital Capacity
20%
Gene Frequency
10%
Genome-Wide Association Study
20%
Immunology
10%
Interferon Regulatory Factor 5
100%
Major Histocompatibility Complex
10%
Promoter Region
10%
Scleroderma
30%
Single Nucleotide Polymorphism
40%
STAT4
10%
Systemic Scleroderma
100%
Biochemistry, Genetics and Molecular Biology
Allele
30%
Autoantibodies
10%
CD247
10%
Forced Vital Capacity
20%
Genetics
10%
Genome-Wide Association Study
20%
IRF5
100%
Major Histocompatibility Complex
10%
Minor Allele Frequency
10%
Promoter Region
10%
Single Nucleotide Polymorphism
30%
Single-Nucleotide Polymorphism
10%
STAT4
10%
Neuroscience
Allele Frequency
10%
Autoantibodies
10%
Genome-Wide Association Study
20%
IRF5
100%
Major Histocompatibility Complex
10%
Promoter Region
10%
Single-Nucleotide Polymorphism
10%
STAT4
10%